Trials / Completed
CompletedNCT03003416
Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy of Ozurdex® as prescribed in clinical practice in France for the treatment of Diabetic Macular Edema (DME).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone intravitreal implant | Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice. |
Timeline
- Start date
- 2017-10-19
- Primary completion
- 2018-12-19
- Completion
- 2018-12-19
- First posted
- 2016-12-28
- Last updated
- 2019-03-14
Locations
25 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03003416. Inclusion in this directory is not an endorsement.